Bridgewater Associates’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bridgewater Associates’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,945	Closed	-$1.11M	–	988
2021 Q4	$1.11M	Buy	+11,945	New	+$787K	0.01%	552

Bridgewater Associates's ARNA Position: Q1 2022 in Review

Bridgewater Associates sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 11,945 shares — an estimated $1.11M sold.

Bridgewater Associates first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $1.11M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Bridgewater Associates reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Bridgewater Associates sold 11,945 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.11M.
Bridgewater Associates first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Bridgewater Associates's Arena Pharmaceuticals Inc position peaked at $1.11M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Bridgewater Associates's 13F filing for Q1 2022, filed 13 May 2022.